TILT Biotherapeutics

TILT Biotherapeutics

TILT Biotherapeutics

Tilt Biotherapeutics, a Helsinki, Finland-based clinical-stage biotechnology company developing cancer immunotherapies.
Type
B2b
Founded
2013
Raised
$17.5M
Follow us
Alexa global traffic share
Latest funding
€6,200,000
Venture capital - 2020
Lifeline Ventures Business Finland European Innovation Council
€10,000,000
Seed fund - 2016
Team Size
2
Employees
€6,200,000 Venture capital
FinSMEs

Tilt Biotherapeutics Raises €6.2M in Funding

€10,000,000 Seed fund
businesswire , N9 - Nordic 9

TILT Biotherapeutics Secures 10 M€ ($10.6M) for Viral Cancer T-Cell Immunotherapy | Business Wire